Revision as of 06:22, 20 June 2013 edit BG19bot (talk \| contribs) 1,005,055 edits m WP:CHECKWIKI error fix for #64. Do general fixes if a problem exists. - using AWB (9239) ← Previous edit		Revision as of 07:31, 23 June 2013 edit undo BG19bot (talk \| contribs) 1,005,055 edits m Fixing section headings Next edit →
Line 44: [[File:Argon plasma used for polymer surface functionalization prior to bonding.Argon plasma used for polymer surface functionalization prior to bonding.png\|125 × 240 pixels.0px\|thumb\|right\|Argon plasma used for polymer surface functionalization prior to bonding.]] ===== Plasma Treatment to Reduce Thrombogenisis ===== Ammonia plasma treatment can be used to attach amine functional groups. These functional groups lock on to anticoagulants like Heparin decreasing thrombogenicity.<ref>{{cite journal \|doi=10.1002/jbm.820270614 \|title=Immobilization of high-affinity heparin oligosaccharides to radiofrequency plasma-modified polyethylene \|year=1993 \|last1=Yuan \|first1=Shengmei \|last2=Szakalas-Gratzl \|first2=Gyongyi \|last3=Ziats \|first3=Nicholas P. \|last4=Jacobsen \|first4=Donald W. \|last5=Kottke-Marchant \|first5=Kandice \|last6=Marchant \|first6=Roger E. \|journal=Journal of Biomedical Materials Research \|volume=27 \|issue=6 \|pages=811–9 \|pmid=8408111}}</ref>

Biomaterial surface modifications: Difference between revisions